Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Molina Healthcare (MOH) Q1 Earnings Miss Mark, Slip Y/Y

Published 05/01/2020, 01:57 AM
Updated 07/09/2023, 06:31 AM

Molina Healthcare (NYSE:MOH), Inc.’s MOH first-quarter 2020 adjusted earnings of $3.02 per share missed the Zacks Consensus Estimate by 0.3% due to escalating expenses. Moreover, the bottom line slid 0.7% year over year.

However, total revenues of $4.5 billion surpassed the consensus mark by 2.7%. The top line rose 10.4% year over year on the back of increased membership.

Quarterly Operational Update

The company’s net income totaled $178 million, down 10.1% year over year.

Total operating expenses increased 11.4% year over year to $4.2 billion.

This deterioration was due to higher medical care costs, depreciation and amortization.

Molina Healthcare’s interest expenses dropped 8.7% year over year to $21 million.

Total membership by Government Program at the end of first quarter stands at 3.4 billion, up 0.3% year over year.

Molina Healthcare (NYSE:HTA), Inc Price, Consensus and EPS Surprise

Molina Healthcare, Inc price-consensus-eps-surprise-chart | Molina Healthcare, Inc Quote

Financial Update

As of Mar 31, 2020, Molina Healthcare’s cash and cash equivalents decreased 3.5% to $2.3 billion from the level at 2019 end.

Total assets rose 5% from the level at 2019 end to $7.1 billion.

The company’s shareholder equity declined nearly 16% from the figure at 2019 end to $1.6 billion.

For the first quarter, net cash flow from operating activities stands at $136 million, down 45.4% year over year.

Share Repurchase Update

Molina Healthcare completed its $500-million share repurchase program.

In the first quarter, it bought back shares worth $450 million.

2020 Guidance

Following first-quarter results, the company reaffirmed its full-year outlook.

It now expects earnings in the range of $11.20-$11.70 per share.

For the current year, the company anticipates total revenues to be $18.3 billion.

Zacks Rank and Performance of Other Players

Molina Healthcare carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Among other players from the medical sector that reported first-quarter results so far, the bottom-line results of Centene (NYSE:CNC) Corp. CNC and Anthem (NYSE:ANTM) Inc. ANTM lagged the Zacks Consensus Estimate while that of Humana Inc (NYSE:HUM). HUM beat the same.

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Humana Inc. (HUM): Free Stock Analysis Report

Molina Healthcare, Inc (MOH): Free Stock Analysis Report

Centene Corporation (CNC): Free Stock Analysis Report

Anthem, Inc. (ANTM): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.